Tulsi Medical & General Stores Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Tulsi Medical & General Stores Pharmaceutical Export Portfolio Dataset — 2 Products, $5.4K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Tulsi Medical & General Stores — Pharmaceutical Exporter Profile (2026) | 2 Products, $5.4K Trade | TransData Nexus

Tulsi Medical & General Stores

Indian Pharmaceutical Exporter · Brand Names & OTC Products Specialist · $5.4K Total Trade · DGFT Verified

Tulsi Medical & General Stores is an Indian pharmaceutical exporter with a total trade value of $5.4K across 2 products in 1 therapeutic categories. Based on 278 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Neosporin ($4.4K), Burnol ($1.0K), .

Tulsi Medical & General Stores — Export Portfolio & Destination Treemap

Tulsi Medical & General Stores pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Tulsi Medical & General Stores? — Company Overview & Market Position

Tulsi Medical & General Stores is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established on March 1, 2020, in Jejuri, Maharashtra, the company operates as a micro enterprise under the MSME classification for the financial year 2024-25. The registered office is located at Milkat No 1610, Morgoan Road, Jejuri, Maharashtra 412303. The proprietor of the company is Mr. Sanjay Thakkar, who also manages the Mumbai branch at 1/204, Sukhasagar Building, Station Avenue Road, Chembur East, Mumbai, Maharashtra 400071. The company primarily engages in the supply and trading of both Ayurvedic and allopathic medicines, including tablets, capsules, syrups, and injections. While specific financial details such as revenue and employee count are not publicly disclosed, the company's operations are managed by a dedicated team under the leadership of Mr. Thakkar.

What Does Tulsi Medical & General Stores Export? — Product Portfolio Analysis

Top Products by Export Value

1Neosporin$4.4K 2

Product Portfolio — Top 2 by Export Value

Tulsi Medical & General Stores exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Neosporin	Brand Names & OTC Products	$4.4K	181	4.4%	8
2	Burnol	Brand Names & OTC Products	$1.0K	97	1.6%	4

Tulsi Medical & General Stores exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $5.4K. The top category is Brand Names & OTC Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Tulsi Medical & General Stores — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Tulsi Medical & General Stores operates manufacturing facilities in Jejuri, Maharashtra, and Mumbai, Maharashtra. The Jejuri facility is situated at Milkat No 1610, Morgoan Road, Jejuri, Maharashtra 412303, and is classified as a micro enterprise under the MSME classification for the financial year 2024-25. The Mumbai branch is located at 1/204, Sukhasagar Building, Station Avenue Road, Chembur East, Mumbai, Maharashtra 400071. Specific details regarding manufacturing capacities and specializations are not publicly available.

3Key Leadership

The company is led by Mr. Sanjay Thakkar, who serves as the proprietor and is actively involved in the management of operations. He oversees the Mumbai branch located at 1/204, Sukhasagar Building, Station Avenue Road, Chembur East, Mumbai, Maharashtra 400071. Specific information regarding other key executives, such as the Chief Financial Officer (CFO) or Chief Operating Officer (COO), is not publicly disclosed.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Tulsi Medical & General Stores Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Tulsi Medical & General Stores has engaged in export activities, with shipments to destinations including Tanzania. For instance, on December 17, 2004, the company exported products such as Bet Novate-C Cream, Itchguard Cream, Cystone Tablets, Kemadrin 2.5 mg, and Daonil Tablets to Zanzibar, Tanzania. However, specific details regarding regulatory filings, approvals, and market access status in the United States, European Union, United Kingdom, Australia, and Japan are not publicly available.

2Emerging Markets

Tulsi Medical & General Stores has engaged in export activities to emerging markets, including Tanzania. For example, on December 17, 2004, the company exported products such as Bet Novate-C Cream, Itchguard Cream, Cystone Tablets, Kemadrin 2.5 mg, and Daonil Tablets to Zanzibar, Tanzania. Specific information regarding the company's presence in Africa, Latin America, and Southeast Asia, as well as WHO prequalification enabling access, is not publicly disclosed.

3Geographic Strategy

Tulsi Medical & General Stores has engaged in export activities to destinations such as Tanzania. For instance, on December 17, 2004, the company exported products including Bet Novate-C Cream, Itchguard Cream, Cystone Tablets, Kemadrin 2.5 mg, and Daonil Tablets to Zanzibar, Tanzania. However, specific details regarding the company's geographic diversification, concentration risk, and strategic direction are not publicly available.

Tulsi Medical & General Stores — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Tulsi Medical & General Stores' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not publicly available. The company's export activities, such as the shipment to Zanzibar, Tanzania, on December 17, 2004, do not provide insights into its FDA-related activities.

2WHO & EU GMP

Specific information regarding Tulsi Medical & General Stores' WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, and European Directorate for the Quality of Medicines & HealthCare (EDQM) status is not publicly available. The company's export activities, such as the shipment to Zanzibar, Tanzania, on December 17, 2004, do not provide insights into its compliance with WHO or EU GMP standards.

3CDSCO & Indian Regulatory

Specific details regarding Tulsi Medical & General Stores' Central Drugs Standard Control Organisation (CDSCO) manufacturing licenses, state drug controller approvals, and export No Objection Certificates (NOCs) are not publicly available. The company's operations are managed by a dedicated team under the leadership of Mr. Sanjay Thakkar, as indicated by the registered office at Milkat No 1610, Morgoan Road, Jejuri, Maharashtra 412303.

Tulsi Medical & General Stores — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Specific information regarding Tulsi Medical & General Stores' competitors in overlapping categories, market share comparison, and head-to-head analysis is not publicly available. The company's export activities, such as the shipment to Zanzibar, Tanzania, on December 17, 2004, do not provide insights into its competitive positioning.

2Key Differentiators

Tulsi Medical & General Stores specializes in the supply and trading of both Ayurvedic and allopathic medicines, including tablets, capsules, syrups, and injections. The company's export activities, such as the shipment to Zanzibar, Tanzania, on December 17, 2004, demonstrate its engagement in international trade. However, specific unique strengths, competitive advantages, and product portfolio distinctions are not publicly disclosed.

3Strategic Position

Specific information regarding Tulsi Medical & General Stores' current strategic direction—whether in generics, specialty, biosimilars, or Contract Development and Manufacturing Organization (CDMO) services—and its future outlook is not publicly available. The company's export activities, such as the shipment to Zanzibar, Tanzania, on December 17, 2004, do not provide insights into its strategic positioning.

Buyer Due Diligence Brief — Evaluating Tulsi Medical & General Stores as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Specific information regarding Tulsi Medical & General Stores' overall track record, export volume and consistency, and reliability indicators is not publicly available. The company's export activities, such as the shipment to Zanzibar, Tanzania, on December 17, 2004, demonstrate its engagement in international trade.

2Certifications to Verify

Importers should verify the following certifications when considering Tulsi Medical & General Stores as a supplier:

FDA Registration: Confirm the company's FDA facility registration status through the FDA's official website.

WHO-GMP Certification: Check for WHO Good Manufacturing Practice certification by consulting the WHO's official website.

EU GMP Certification: Verify EU Good Manufacturing Practice certification through the European Medicines Agency (EMA) website.

Frequently Asked Questions — Tulsi Medical & General Stores

How many pharmaceutical products does Tulsi Medical & General Stores export from India?

Tulsi Medical & General Stores exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Neosporin ($4.4K), Burnol ($1.0K). Total export value is $5.4K.

What is Tulsi Medical & General Stores's total pharmaceutical export value?

Tulsi Medical & General Stores's total pharmaceutical export value is $5.4K, based on 278 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Tulsi Medical & General Stores cover?

Tulsi Medical & General Stores exports across 1 therapeutic categories. The largest are Brand Names & OTC Products (100.0%, 2 products).

Get Full Tulsi Medical & General Stores Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.